(Q36791600)

16 August 2017

1 reference

title

Risk and predictability of drug interactions in the elderly (English)

1 reference

16 August 2017

René H Levy

1

1 reference

16 August 2017

Carol Collins

series ordinal

2

1 reference

16 August 2017

publication date

1 January 2007

1 reference

International Review of Neurobiology

16 August 2017

published in

1 reference

16 August 2017

volume

81

1 reference

16 August 2017

page(s)

235-251

1 reference

Gemfibrozil interaction with warfarin sodium (coumadin)

16 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2981015-9

7 January 2021

Effect of venlafaxine on imipramine metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2981015-9

7 January 2021

Effect of venlafaxine versus fluoxetine on metabolism of dextromethorphan, a CYP2D6 probe

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2981015-9

7 January 2021

No influence of the antidepressant paroxetine on carbamazepine, valproate and phenytoin

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2981015-9

7 January 2021

Pharmacogenetics and enzyme induction/inhibition properties of antiepileptic drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2981015-9

7 January 2021

Bidirectional interaction of valproate and lamotrigine in healthy subjects.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2981015-9

7 January 2021

Fluoxetine kinetics and protein binding in normal and impaired renal function

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2981015-9

7 January 2021

Interactions between calcium channel blockers and the anticonvulsants carbamazepine and phenytoin

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2981015-9

7 January 2021

Molecular genetics of CYP2D6: clinical relevance with focus on psychotropic drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2981015-9

7 January 2021

Fluoxetine impairs the CYP2D6-mediated metabolism of propafenone enantiomers in healthy Chinese volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2981015-9

7 January 2021

Interaction between phenytoin and fluoxetine

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2981015-9

7 January 2021

Changing presentation of seizures with aging: clinical and etiological factors

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2981015-9

7 January 2021

Ticlopidine inhibits phenytoin clearance

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2981015-9

7 January 2021

Elevated serum carbamazepine concentrations following diltiazem initiation

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2981015-9

7 January 2021

Antidepressant drug interactions and the cytochrome P450 system. The role of cytochrome P450 2D6.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2981015-9

7 January 2021

Evaluation of potential losartan-phenytoin drug interactions in healthy volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2981015-9

7 January 2021

Implications of cytochrome P450 interactions when prescribing medication for hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2981015-9

7 January 2021

Evaluation of the effect of fluoxetine on the formation of carbamazepine epoxide

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2981015-9

7 January 2021

Prevention of a first stroke: a review of guidelines and a multidisciplinary consensus statement from the National Stroke Association

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2981015-9

7 January 2021

Effect of fluoxetine on carvedilol pharmacokinetics, CYP2D6 activity, and autonomic balance in heart failure patients

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2981015-9

7 January 2021

Impact of polymorphisms of cytochrome-P450 isoenzymes 2C9, 2C19 and 2D6 on plasma concentrations and clinical effects of antidepressants in a naturalistic clinical setting

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2981015-9

7 January 2021

Increased carbamazepine plasma concentrations after fluoxetine coadministration

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2981015-9

7 January 2021

New antiepileptic drugs: review on drug interactions

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2981015-9

7 January 2021

Carbamazepine-induced acceleration of diphenylhydantoin and warfarin metabolism in man

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2981015-9

7 January 2021

Elevated serum phenytoin concentrations associated with coadministration of sertraline

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2981015-9

7 January 2021

Paroxetine affects metoprolol pharmacokinetics and pharmacodynamics in healthy volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2981015-9

7 January 2021

Stroke and the risk of Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2981015-9

7 January 2021

Clinical pharmacokinetics of angiotensin converting enzyme (ACE) inhibitors in renal failure

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2981015-9

7 January 2021

Toxic reaction following the combined administration of fluoxetine and phenytoin: two case reports

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2981015-9

7 January 2021

Human P450 metabolism of warfarin

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2981015-9

7 January 2021

Depression in epilepsy: prevalence, clinical semiology, pathogenic mechanisms, and treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2981015-9

7 January 2021

Lamotrigine toxicity secondary to sertraline

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2981015-9

7 January 2021

Warfarin-carbamazepine interaction

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2981015-9

7 January 2021

Ticlopidine-induced phenytoin toxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2981015-9

7 January 2021

Epilepsy in the elderly: some clinical and pharmacotherapeutic aspects

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2981015-9

7 January 2021

Oxcarbazepine does not affect the anticoagulant activity of warfarin

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2981015-9

7 January 2021

Metabolism of carteolol by cDNA-expressed human cytochrome P450.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2981015-9

7 January 2021

Antiepileptic drug use in nursing home residents: effect of age, gender, and comedication on patterns of use.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2981015-9

7 January 2021

Pharmacokinetic drug interaction potential of selective serotonin reuptake inhibitors.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2981015-9

7 January 2021

Depressive disorder, dysthymia, and risk of stroke: thirteen-year follow-up from the Baltimore epidemiologic catchment area study

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2981015-9

7 January 2021

Substituting carbamazepine with oxcarbazepine increases citalopram levels. A report on two cases

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2981015-9

7 January 2021

Incidence and predictors for post-stroke epilepsy. A prospective controlled trial. The Akershus stroke study

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2981015-9

7 January 2021

Verapamil potentiates carbamazepine neurotoxicity: a clinically important inhibitory interaction

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2981015-9

7 January 2021

Pharmacokinetic interactions of timolol with vasodilating drugs, food and phenobarbitone in healthy human volunteers.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2981015-9

7 January 2021

Effect of carbamazepine on Coumadin metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2981015-9

7 January 2021

Reduced plasma nisoldipine concentrations in phenytoin-treated patients with epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2981015-9

7 January 2021

Lack of effect of citalopram on the steady-state pharmacokinetics of carbamazepine in healthy male subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2981015-9

7 January 2021

Efficacy of statin therapy: possible effect of phenytoin

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2981015-9

7 January 2021

Warfarin and Phenytoin Interaction

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2981015-9

7 January 2021

Glucuronidation converts gemfibrozil to a potent, metabolism-dependent inhibitor of CYP2C8: implications for drug-drug interactions

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2981015-9

7 January 2021

Pharmacological and clinical aspects of antiepileptic drug use in the elderly

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2981015-9

7 January 2021

Significant reduction of sertraline plasma levels by carbamazepine and phenytoin

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2981015-9

7 January 2021

Mechanistic studies on metabolic interactions between gemfibrozil and statins

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2981015-9

7 January 2021

Lack of effect of repeated administration of levetiracetam on the pharmacodynamic and pharmacokinetic profiles of warfarin

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2981015-9

7 January 2021

Current and emerging pharmacological treatment options for dementia

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2981015-9

7 January 2021

Ticlopidine impairs phenytoin clearance: a case report

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2981015-9

7 January 2021

Poststroke depression: prevalence, diagnosis, treatment, and disease progression

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2981015-9

7 January 2021

Pharmacokinetic and pharmacodynamic alterations of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors: drug-drug interactions and interindividual differences in transporter and metabolic enzyme functions

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2981015-9

7 January 2021

Gemfibrozil and its glucuronide inhibit the organic anion transporting polypeptide 2 (OATP2/OATP1B1:SLC21A6)-mediated hepatic uptake and CYP2C8-mediated metabolism of cerivastatin: analysis of the mechanism of the clinically relevant drug-drug inter

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2981015-9

7 January 2021

The pharmacokinetic and pharmacodynamic consequences of the co-administration of lamotrigine and a combined oral contraceptive in healthy female subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2981015-9

7 January 2021

Drug-drug interaction studies with mirtazapine and carbamazepine in healthy male subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2981015-9

7 January 2021

Duloxetine is both an inhibitor and a substrate of cytochrome P4502D6 in healthy volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2981015-9

7 January 2021

Concomitant use of mirtazapine and phenytoin: a drug-drug interaction study in healthy male subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2981015-9

7 January 2021

Carbamazepine augmentation in depressive patients non-responding to citalopram: a pharmacokinetic and clinical pilot study

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2981015-9

7 January 2021

Epilepsy in elderly people

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2981015-9

7 January 2021

Differential effects of valproic acid and enzyme-inducing anticonvulsants on nimodipine pharmacokinetics in epileptic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2981015-9

7 January 2021

Potential interaction between warfarin and fluvastatin

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2981015-9

7 January 2021

When drug therapy gets old: pharmacokinetics and pharmacodynamics in the elderly

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2981015-9

7 January 2021

Venlafaxine and metabolites are very weak inhibitors of human cytochrome P450-3A isoforms

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2981015-9

7 January 2021

Citalopram and desmethylcitalopram in vitro: human cytochromes mediating transformation, and cytochrome inhibitory effects.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2981015-9

7 January 2021

Carbamazepine decreases antihypertensive effect of nilvadipine

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2981015-9

7 January 2021

Influence of single and repeated doses of oxcarbazepine on the pharmacokinetic profile of felodipine

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2981015-9

7 January 2021

Clinical pharmacokinetics of fluvastatin

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2981015-9

7 January 2021

Seizure disorders: the changes with age.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2981015-9

7 January 2021

10.1016/S0074-7742(06)81015-9

Identifiers

DOI

1 reference

16 August 2017

1 reference